Renowned virologist and emeritus professor, Dr. Erik De Clercq began his medical career in 1966. Under his leadership, scientists at the Rega Institute for Medical Research discovered some of the first anti-HIV medications.
De Clercq played a central role in developing the paradigm-shifting concept of combination therapy for HIV, which is still the most effective treatment strategy for HIV/AIDS patients today. Over his prodigious career, De Clercq’s research has focused on the development of new therapies, particularly the development of new agents that fight viral infections.
He is widely recognized for his seminal work in the field of nucleotide analogs, the first broad-spectrum antivirals, sparking a new era in antiviral development.